Ramana S. S Moorthy

Dr. Ramana S. S Moorthy


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Survey of Ophthalmology
Verified
Journal Article
Closed access
RMRamana S. S Moorthy
Ramana S. S Moorthy
SVShailaja Valluri
Shailaja Valluri
NRNarsing A. Rao
Narsing A. Rao

1 January 2013 in Journal of Ophthalmic Inflammation and Infection
Verified
Journal Article
Open access
PDF file
NLNikolas Js London
Nikolas Js London
SGSunir J Garg
Sunir J Garg
RMRamana S. S Moorthy
Ramana S. S Moorthy
ECEmmett T Cunningham
Emmett T Cunningham
A number of medications have been associated with uveitis. This review highlights both well-established and recently reported systemic, topical, intraocular, and vaccine-associated causes of drug-induced uveitis, and assigns a quantitative score to each medication based upon criteria originally described by Naranjo and associates.

1 May 2019 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
KIKengo Inagaki
Kengo Inagaki
BKBrian Kirmse
Brian Kirmse
Richard BradburyRichard Bradbury
Richard Bradbury
RMRamana S. S Moorthy
Ramana S. S Moorthy
IAIrene Arguello
Irene Arguello
CHCharlotte V. Hobbs
Charlotte V. Hobbs
Ocular toxocariasis can be vision threatening, and is commonly reported from tropical or subtropical regions. Knowledge of clinical manifestations from the United States, particularly in underserved areas such as the American South, is lacking. We report three cases of ocular toxocariasis in individuals from the Mississippi Delta, a rural community with prevalent poverty. Visual acuity was severely affected in two of the three cases. Increased awareness of ocular toxocariasis, which may have under-recognized frequency, will contribute to prompt diagnosis and treatment, which will ultimately improve patient health in the region.

1 February 2011 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
BDB. Travis Dastrup
B. Travis Dastrup
LCLouis Cantor
Louis Cantor
RMRamana S. S Moorthy
Ramana S. S Moorthy
DVDaniel Vasconcelos-Santos
Daniel Vasconcelos-Santos
NRNarsing Rao
Narsing Rao
Letter from JAMA Ophthalmology — An Unusual Manifestation of Herpes Simplex Virus–Associated Acute Iris Depigmentation and Pigmentary Glaucoma

25 January 2024 in Journal of Neuro-Ophthalmology
Verified
Journal Article
Open access
SSSharon Sabapathypillai
Sharon Sabapathypillai
VMVictoria J Miller
Victoria J Miller
ASAkbar Shakoor
Akbar Shakoor
APAlan G Palestine
Alan G Palestine
JTJennifer E Thorne
Jennifer E Thorne
LHLynn M Hassman
Lynn M Hassman
Background: Optic disc edema is a feature of many ophthalmic and neurologic conditions. It remains an underappreciated feature of birdshot chorioretinitis (BSCR), leading to delay in diagnosis and treatment. The purpose of our study was to identify clinical features that are concomitant with optic disc edema and suggest a diagnosis of BSCR. Methods: Retrospective multicenter case series of 29 patients who were referred to a neuro-ophthalmologist or uveitis specialist for evaluation of disc edema and were ultimately diagnosed with BSCR. Results: Fifty-four eyes of 30 patients, from the practices of 15 uveitis specialists, met the eligibility criteria. In addition to disc edema, concomitant features in all patients included vitritis, chorioretinal lesions, and retinal vasculitis. Visual recovery to 20/40 or better occurred in 26 of 29 patients. Visual acuity remained 20/100 or worse in 2 patients previously diagnosed with idiopathic intracranial hypertension, 1 patient previously diagnosed with optic neuritis, and 1 patient for whom treatment was delayed for years, leading to optic disc atrophy. Conclusions: Optic disc edema is a presenting feature in some cases of BSCR. A diagnosis of BSCR should be considered when disc edema occurs with vitritis, chorioretinal inflammation, and retinal vasculitis. Patients should be referred to a uveitis specialist for treatment.

18 July 2024 in Life
Verified
Journal Article
Open access
PDF file
Mariana DupontMariana Dupont
Mariana Dupont
EAEdmund Arthur
Edmund Arthur
YSYazen Shihab
Yazen Shihab
Madelyn KennyMadelyn Kenny
Madelyn Kenny
SRSwetha Ravichandran
Swetha Ravichandran
MGMaria B. Grant
Maria B. Grant
(1) Background: Previously, VESsel GENeration (VESGEN) software was used to map and quantify vascular changes observed on fluorescein angiography (FA) in subjects (n = 15 eyes) with retinal pathology ranging from mild non-proliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR). In the current study, we used VESGEN for the assessment of individuals with early-stage NPDR imaged by FA (Cohort 1) and by optical coherence tomography angiography (OCTA; Cohort 2). (2) Methods: Cohort 1 included type 2 diabetics (T2D), represented 21 eyes (ranging from no DR to moderate DR), and also included nondiabetic controls (NDC; n = 15 eyes). Cohort 2 consisted of 23 eyes from T2D subjects (including no DR subjects and moderate DR subjects) and NDC (n = 18 eyes). (3) Results: In the FA-VESGEN study, total tortuosity (Tv) of microvessels (G ≥ 6) increased in T2D with mild DR compared to the controls. In contrast, the VESGEN analysis of OCTA images showed that vessel length (characterized as density) was lower in T2D subjects before the diagnosis of DR and following the diagnosis of DR when compared to the controls. Additionally, T2D showed a significant decrease in vessel area (density). (4) Conclusions: FA elucidated the vessel morphology of small-generation microvessels to a greater degree than OCTA; however, OCTA identified changes in vessel density better than FA. VESGEN analysis can be used with both standard FA and OCTA to facilitate our understanding of early events in DR, including before the clinical diagnosis of DR.